Safety, efficacy, and tolerability of memantine for cognitive and adaptive outcome measures in adolescents and young adults with Down syndrome: a randomised, double-blind, placebo-controlled phase 2 trial-Reference-Cited by-同舟云学术

Safety, efficacy, and tolerability of memantine for cognitive and adaptive outcome measures in adolescents and young adults with Down syndrome: a randomised, double-blind, placebo-controlled phase 2 trial

Published:2022-01 Issue:1 Volume:21 Page:31-41
ISSN:1474-4422
Container-title:The Lancet Neurology
language:en
Short-container-title:The Lancet Neurology

Author:

Costa Alberto C S,Brandão Ana C,Boada Richard,Barrionuevo Veridiana L,Taylor Hudson G,Roth Elizabeth,Stasko Melissa R,Johnson Mark W,Assir Fernanda F,Roberto Maria P,Salmona Patrícia,Abreu-Silveira Guilherme,Bederman Ilya,Prendergast Erin,Hüls Anke,Abrishamcar Sarina,Mustacchi Zan,Scheidemantel Thomas,Roizen Nancy J,Ruedrich Stephen

Publisher

Elsevier BV

Subject

Neurology (clinical)

Reference30 articles.

1. Down syndrome and genetics: a case of linked histories;Patterson;Nat Rev Genet,2005

2. National population-based estimates for major birth defects, 2010–2014;Mai;Birth Defects Res,2019

3. 50 years with Down syndrome: a longitudinal study;Carr;J Appl Res Intellect Disabil,2018

4. Caregiver report of executive functioning in a population-based sample of young children with Down syndrome;Lee;Am J Intellect Dev Disabil,2011

5. The neuropsychology of Down syndrome: evidence for hippocampal dysfunction;Pennington;Child Dev,2003

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in Alzheimer's disease: A multifaceted review of potential therapies and diagnostic techniques for early detection;Neurochemistry International;2024-07

2. "It Is Easy Using My Apps:" Understanding Technology Use and Needs of Adults with Down Syndrome;Proceedings of the CHI Conference on Human Factors in Computing Systems;2024-05-11

3. Alzheimer’s drugs, APPlication for Down syndrome?;Ageing Research Reviews;2024-04

4. Unlocking cognitive potential: a comprehensive review of neurocognitive interventions in Down Syndrome;InterConf;2024-03-20

5. The role of Memantine in slowing cognitive decline in patients with Down syndrome–A systematic review and meta analysis;Brain Disorders;2024-03